Furthermore, the beneficial effect of NAC on most sleep-related abnormalities in Gclm KO mice points to the need for assessing sleep quantity (architecture of the sleep-wake cycle) and sleep quality (oscillations) during clinical trials using antioxidant compounds in subjects with schizophrenia. The gene discussed is GCLM; the disease is schizophrenia.